ABSTRACT
Poly cystic ovarian syndrome is a condition characterised by a wide range of signs and symptoms including menstrual irregularities, obesity, acne, hirsutism and is causing adverse effects on metabolic and endocrinal system. Exact etiology and pathophysiology is still unclear but it’s having a strong familial predisposition. This is a case report on an anovulatory infertility caused by PCOS. A 27-year-old female patient presented to the Streeroga OPD at ITRA On December 29, 2020, complaining of infertility, irregular and delayed menstruation, and weight gain over the past three years. She has been taking allopathic medicine for the same for the last two years. During her initial opd visit, she received a thorough medical history as well as all relevant clinical, physical, and laboratory tests. Bulky ovaries with polycystic morphology were discovered on sonography. Anovulatory factor infertility owing to PCOS was determined based on clinical symptoms and sonography. Pathadi choorna and Arogyavardhini rasa were chosen as medications and Samana oushadha was chosen as the line of management. The patient was counselled on lifestyle changes, the need of exercise, and correction of food habits. Patient was under medication for a period of 5 months. Patient got conceived after that and on 8th February 2022 she gave birth to a healthy male baby per vaginally with a baby weight of 3.2 kg.
ABSTRACT
Bacground: Highly Active Antiretroviral Therapy (HAART) was introduced in National AIDS Control Programme in 2004 to reduce the morbidity and mortality among those affected with HIV/AIDS. Tuberculosis, being an important coinfection, its emergence / occurrence in post-HAART period has potential implications. Objective:: Primary objectives were to study the incidence of post- HAART tuberculosis in HIV patients and to identify the possible risk factors. It was also intended to understand the clinical and immunological profile of this important condition. Methodology: Eligible adults and adolescents with HIV disease enrolled on HAART at Government Hospital of Thoracic Medicine, Tambaram Sanatorium, Chennai, from April, 2004 to March, 2007, formed the study population. They were monitored and screened for the occurrence of tuberculosis after commencing HAART. Clinical details and immunological profile of these patients were analysed. Results: Two hundred and sixty-two patients (5.1%) of 5099 patients followed-up for one to four years were found to have Post HAART TB with 100-person year risk of 2.83. Post HAART TB occurred predominantly in men (67.6%) and in 31- 44 years age group (69.8%) with 100-person year risk being 3.26 and 2.83 respectively. Pulmonary, Extra-pulmonary and disseminated tuberculosis were found to occur in the frequencies of 78%, 16% and 6% respectively. A total of 144 patients (54.9%) developed tuberculosis within six months and this number increased to 202 (77%) by 12 months. 230 patients (87.7%) had base level CD4 cell count < 200 / mm3. Conclusion: Tuberculosis was found to occur pre-dominantly in adult male patients with HIV during the first year after the initiation of HAART. Significantly, occurrence of Post HAART TB remained almost the same (5%) among patients treated for TB prior to the initiation of HAART.
ABSTRACT
Free antiretroviral therapy is being given to eligible people living with HIV in India since April 2004. Govt. Hospital of Thoracic Medicine, Tambaram Sanatorium, Chennai is one of the largest centers managing HIV/AIDS patients with antiretroviral therapy in India.This study finds out the incidence of tuberculosis as the manifestation of ‘Immune Reconstitution Syndrome (IRS)’ after the initiation of Antiretroviral therapy in patients with HIV/AIDS. All the patients, placed under ART, were followed up for the occurrence of tuberculosis from April 2004 to December 2005 at GHTM, Tambaram Sanatorium, Chennai. 2330 HIV patients were initiated antiretroviral therapy till December 2005 and of whom 1409 (61%) were already treated for tuberculosis. 302 (12.9%) had IRS and 81 (3.5%) had tuberculosis, as the component of IRS. Occurrence of tuberculosis as IRS manifestation is significantly high after antiretroviral therapy. This results in starting or restarting anti tuberculosis treatment with the changed or modified antiretroviral therapy in a large number of patients, escalating treatment cost.